Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer

This study has been terminated.
(This study was terminated due to low accrual.)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ) Identifier:
First received: September 11, 2004
Last updated: October 25, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)